Related Experiment Videos
[The infection theory in atherosclerosis]
Archives Des Maladies Du Coeur Et Des Vaisseaux
|December 2, 1998
Summary
Infectious agents may cause atherosclerosis, a chronic inflammatory disease. Emerging evidence suggests antibiotics may treat coronary artery disease, opening new avenues for prevention and treatment.
Area of Science:
- Cardiovascular Research
- Infectious Diseases
- Inflammation Biology
Background:
- Atherosclerosis exhibits characteristics of chronic inflammation.
- Infectious agents are investigated for their role in initiating and perpetuating atherosclerotic inflammation.
- Specific microbial characteristics (wide distribution, arterial tropism, persistence) are relevant to the infectious theory.
Purpose of the Study:
- To explore the potential infectious etiology of atherosclerosis.
- To review evidence implicating specific microbes in human atherosclerosis.
- To assess the impact of antimicrobial therapy on coronary artery disease prognosis.
Main Methods:
- Review of experimental, sero-epidemiologic, and pathological evidence.
- Investigation of microbial involvement (cytomegalovirus, Chlamydia pneumoniae, Helicobacter pylori).
- Analysis of pilot therapeutic studies using macrolide antibiotics for coronary artery disease.
Main Results:
- Chlamydia pneumoniae is a suspected contributor to atherosclerosis.
- Pilot studies indicate macrolide antibiotic treatment may improve coronary artery disease outcomes.
- Evidence for infectious causes of atherosclerosis is currently not definitively established.
Conclusions:
- An infectious etiology for atherosclerosis warrants serious consideration and further investigation.
- Positive results from macrolide therapy could revolutionize atherosclerosis management.
- Ongoing clinical and experimental research is crucial for validating the infectious theory.